Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/07/3005 : 06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
2024/07/3005 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CHKChesapeake Energy Corporation
2024/07/3005 : 06Edgar (US Regulatory)Form 8-K - Current reportNYSE:CWKCushman and Wakefield PLC
2024/07/3005 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HSIIHeidrick and Struggles International Inc
2024/07/3005 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLKNMillerKnoll Inc
2024/07/3005 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:TRVThe Travelers Companies Inc
2024/07/3005 : 06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:UUnity Software Inc
2024/07/3005 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCNEPCNB Financial Corporation
2024/07/3005 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MRDBMariaDB PLC
2024/07/3005 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TMDXTransMedics Group Inc
2024/07/3005 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HMSTHomeStreet Inc
2024/07/3005 : 05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ETSTEarth Science Tech Inc (PK)
2024/07/3005 : 05Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NYSE:LGF.BLions Gate Entertainment Corp
2024/07/3005 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PFISPeoples Financial Services Corporation
2024/07/3005 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOFBranchOut Food Inc
2024/07/3005 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DKDCUData Knights Acquisition Corporation
2024/07/3005 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:FORForestar Group Inc
2024/07/3005 : 05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CNETZW Data Action Technologies Inc
2024/07/3005 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KFRCKforce Inc
2024/07/3005 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FLICFirst of Long Island Corporation
2024/07/3005 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/07/3005 : 05Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:VVPRVivoPower International PLC
2024/07/3005 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VVPRVivoPower International PLC
2024/07/3005 : 05Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NASDAQ:PSECProspect Capital Corporation
2024/07/3005 : 05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ROGRogers Corp
2024/07/3005 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MRDBMariaDB PLC
2024/07/3005 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPWRSunPower Corporation
2024/07/3005 : 05GlobeNewswire Inc.Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024NASDAQ:SPROSpero Therapeutics Inc
2024/07/3005 : 05Edgar (US Regulatory)Form F-6 POS - Post-effective amendments for immediately effective filingUSOTC:BRPPFBrookfield Office Properties Inc (GM)
2024/07/3005 : 05Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:PMCBPharmaCyte Biotech Inc

最近閲覧した銘柄